Skip links

JimLegal24 is here to help!

Need Help Now? Call our 24 Hour Hotline.

Call Us Now

Were you diagnosed with cancer after years of taking Zantac?

For million of Americans who experienced heartburn, over-the-counter and prescription Zantac provided daily relief for the condition. In late 2019, independent testing revealed high levels of a carcinogen called NDMA, which set off a chain reaction of recalls. Now, those who were diagnosed with cancer after years of taking Zantac may be entitled to compensation.

Zantac (ranitidine) is a heartburn medication called a histamine-2 blocker, or H2 blocker. It works to both relieve and prevent heartburn and was a go-to medication for millions of people suffering from heartburn. In September 2019, the FDA announced that tests had found unacceptable levels of NDMA, a known carcinogen, in some generic forms of Zantac. By October 2019, some pharmacies were pulling all forms of generic ranitidine from shelves, and in April 2020, the FDA issued a recall for all ranitidine and Zantac products. The FDA noted that the NDMA in Zantac and ranitidine increased over time when stored in less than optimal conditions.

If you or a family member took Zantac and was later diagnosed with stomach, esophageal or another form of cancer, you better call Jim at James F. Humphreys & Associates, L.C. Call us at 304-303-5510, or fill out this online contact form, and one of our team members will get back to you as soon as possible.

Call Now: 304-303-5510


Get a Free Case Evaluation

This field is for validation purposes and should be left unchanged.